Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Exogene's low-cost approach to fermentation

Exogene Corp. hopes to halve the manufacturing costs of therapeutics produced through fermentation, by coupling agroprocessing technology with its pharmacologically active molecules.

Privately held Exogene uses genetic methods to improve production strains of the aerobic microbes used to

Read the full 370 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers